Expression of angiopoietin-2 and vascular endothelial growth factor in oral squamous cell carcinoma and its significance

Chinese-German Journal of Clinical Oncology

Volumn 4, Issue 4, 2005, Pages 232-237

  Li, Chao ^a   Feng, Hongchao ^b   Song, Yufeng ^b  

^a SICHUAN CANCER HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Angiopoietin 2; Microvessel density; Mouth neoplasms; VEGF; vessel maturation

Indexed keywords

EID: 24944453585     PISSN: 16101979     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10330-005-0367-0     Document Type: Article

References (15)

1. Song YF, Wen YM, Duan XF. Experiment study of bloodstream volume and angiogenesis with the relationship of carcinoma growth during the cheek pouch cancerigation. J Gui Yang Medical College (Chinese), 1997, 22: 323-325.
2. Feng HC, Song YF, Wen YM. A study on the correlation between vascular endothelial growth foctor and tumor-associated macrophages in tumour angiogenesis of human oral squamous-cell carcinomas. Chin J Clin Oncol (Chinese), 2004, 31: 435-437.
3. Alcalde RE, Terakado N, Otsuki K, et al. Angiogenesis and expression of platelet-derived endothelial cell growth factor in oral squamous cell carcinoma. Oncology, 1997, 54: 324-328.
4. Lopez-Graniel CM, Tamez de Leon D, Meneses-Garcia A, et al. Tumor angiogenesis as a prognostic factor in oral cavity carcinomas. J Exp Clin Cancer Res, 2001, 20: 463-468.
5. Wu H, Deng ZD, Chen DE. The partial purification of angiogenesis foctor of human osteosarcoma. Chinese-German J Clin Oncol, 2002, 1: 94-97.
6. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature, 2000, 407: 242-248.
7. Loughna S, Sato TN. Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol, 2001, 20: 319-325.
8. Shepro D, Morel NM. Pericyte physiology. FASEB J, 1993, 7: 1031-1038.
9. Eberhard A, Kahlert S, Goede V, et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies. Cancer Res, 2000, 60: 1388-1393.
10. Koga K, Todaka T, Morioka M, et al. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res, 2001, 61: 6248-6254.
11. Ochiumi T, Tanaka S, Oka S, et al. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int J Oncol, 2004, 24: 539-547.
12. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995, 36: 169-180.
13. Spiro RH, Alfonso AE, Farr HW, et al. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg, 1974, 128: 562-567.
14. Tanaka F, Ishikawa S, Yanagihara K, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res, 2002, 62: 7124-7129.
15. Gee MS, Procopio WN, Makonnen S, et al. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am J Pathol, 2003, 162: 183-193.